vialroom

#retatrutide 2025-01-14

Tuesday29 messages7 participantstimes are UTC
Highlights from this day
  • drawup_dee — how long before people saw the first change at 0.25 21:23
  • lipase_lore — update on the earlier thing does the glucagon arm explain the heart rate or is that unrelated 22:05
  • bench_notes — the half life supports weekly dosing and thats what ive done from the start, i think 22:30
C1

is the glucagon arm what people mean by the energy expenditure thing

NC

came off at 14 weeks because my resting rate stayed elevated and i didnt like it

DD

i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind

C1

slightly off topic but held at 1.7 for 20 months and it never plateaued for me, which i cant explain

DD

how long before people saw the first change at 0.25

👀16👍7

the purity spread across lots worries me more than the molecule does, still working it out

the honest position is this has less human evidence behind it than anything else discussed here, someone check my working
research use only is on every vial and i treat it as exactly that, nobody here is prescribing

logging rhr daily

no long term data

LL

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
held at 12 for 8 months and it never plateaued for me, which i cant explain

RR

triple agonist meaning GLP-1, GIP and glucagon, have i got that right

research use only is on every vial and i treat it as exactly that, nobody here is prescribing

update on the earlier thing does the glucagon arm explain the heart rate or is that unrelated

🔥14📉5🙏1

is there any long term safety data at all or is it phase 2 and hope

BN

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

BN

i said 3 months ago that my heart rate had settled and it has stayed settled since
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

the half life supports weekly dosing and thats what ive done from the start, i think

🧪5❤️18
LL

sorry to jump in there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

VB

Batch lookup B-0329: 3 independent reports on file, earliest 2024-11-09.

VB

Inter-lab diff for lot E-2205: 99.4% vs 97.4%. Within expected range.